Sequence newsletter - Issue 9 - 2020
Published on 07/02/2020
Latest issue of Sequence newsletter by Mills & Reeve. We take a look at some of the key legal and business issues affecting the sector.
- Where next for cannabis -based medicines?
- Data protection - financial penalties under GDPR start to emerge
- AI and Healthtech
- Compensating exceptional inventors within your team? what's appropriate?
- When signature branding for medicine goes wrong
- Might you be entering into legal contracts by mistake?
Sequence newsletter- Issue 9 - January 2020
If you would like to subscribe to future issues, you can manage your preferences here:
https://update.mills-reeve.com/26/7/forms/subscribeconsentia.asp
